GSK's Kathy Rouan Tells Inside Scoop On Surpassing Scandal
This article was originally published in Scrip
Executive Summary
Dr. Kathy Rouan, a veteran member of GlaxoSmithKline plc's management team and current senior vice president and head of R&D for its dermatology business unit Stiefel, has experienced the big pharma's growth through two major mergers and various changes in management, environment and mission.